E. R. Squibb & Sons Limited

Uxbridge Business Park , Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: Medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Patient Information Leaflet last updated on the eMC: 09/03/2011
PIL Kenalog Intra-Articular/Intramuscular Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 05/02/2010 and displayed until 09/03/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/01/2010 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 13/08/2008 and displayed until 28/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 01/05/2007 and displayed until 13/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 20/09/2006 and displayed until 01/05/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/05/2006 and displayed until 20/09/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   triamcinolone acetonide